Hai Pan, Ph.D.
Founder, Chairman & CEO
Dr. Pan is an accomplished R&D executive and entrepreneur with more than 20 years of industry experience. His track record of success includes advancing over 20 biologics and small molecule drug candidates to clinical development. As founder and CEO of Sciwind Biosciences, Dr. Pan has led the company in building an industry-leading pipeline with an emphasis on treating metabolic disease.
Prior to founding Sciwind Biosciences, Dr. Pan held leadership roles at Amgen, as well as at China-based Kawin Biotech. Dr. Pan is an accomplished researcher with deep knowledge and expertise in drug development for various therapeutic areas, including metabolic disease and infectious disease.
Xinle Wu, Ph.D.
Chief Scientific Officer & Head of Research
Dr. Wu has more than 15 years of pharmaceutical industry experience with a strong track record in research and development of innovative medicines. Prior to joining Sciwind Biosciences, Dr. Wu served as Senior Scientific Director at Lilly China Innovation and Partnership and Lilly China R&D Center. Dr. Wu also worked at Amgen as a Principal Scientist.
Dr. Wu received his Ph.D. from Case Western Reserve University and completed his postdoctoral training at University of Texas Southwestern Medical Center.